A patent allows an inventor to exclude others from making, using or selling the claimed invention for a limited period of time, now 20 years from the filing of the patent application.
A U.S. provisional patent allows an inventor to file for protection of his or her invention, without a formal patent claim, oath or declaration, or any information disclosure (prior art) statement.
Notably the patent allows for a bit of cheating on the system's part: it doesn't have to scramble during the first few seconds to identify your accent, but can stack the deck a bit by checking the device's location, phone number, previous accents encountered on that line or, of course, simply allowing the speaker to pick their accent manually.
Filing a patent allows you to stake a claim to that IP, monetize it through licensing and collaborate with others while protecting what's yours.
Lilly's fall emphasizes a key weakness of many big pharmaceutical companies: The expiration of a major patent allows generic drugs to enter the market and usually eat away most of the branded drug's sales within two years.
This patent allows the company to charge a higher price for the medication, since they now have a monopoly over the market, and health services like the NHS more of less have their hands tied when it comes to paying these inordinately high costs—at least until the patent expires.
However, holding a provisional patent allows you to be the first to stake your claim to the invention.
Mr. Joel received more than 70 patents, but he was perhaps best known for No. 3,663,762, a 1972 patent that allows a cellphone user to make an uninterrupted call while moving from one cell region to another.
Currently, drug companies can receive a special five-year extension on the length of an Australian patent (allowing them to sell a patented drug at much higher prices).
This might save time and money for firms which would be affected by a dodgy patent, allowing them to argue things out at an early stage rather than later on in a costly courtroom.One of the biggest criticisms of the bill concerns the PTO's funding, which some think should be increased so that the office can hire and keep the best examiners and so reduce a huge backlog of applications.
